Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Amortization - Deferred Charges EBIAT Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Outstanding Shares Outstanding Wages, Salaries and Other

Armata Pharmaceuticals (ARMP) Shares Issued (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Shares Issued for 4 consecutive years, with $12.2 million as the latest value for Q4 2018.

Quarterly Shares Issued rose 12266.67% to $12.2 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $12.2 million through Dec 2018, up 253.07% year-over-year, with the annual reading at $44.4 million for FY2022, 68.67% up from the prior year.
Shares Issued hit $12.2 million in Q4 2018 for Armata Pharmaceuticals, up from -$193000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $13.0 million in Q1 2015 to a low of -$12.0 million in Q3 2015.
Historically, Shares Issued has averaged $1.8 million across 4 years, with a median of $99000.0 in 2017.
Biggest five-year swings in Shares Issued: plummeted 97.04% in 2017 and later surged 12266.67% in 2018.
Year by year, Shares Issued stood at -$12.0 million in 2015, then surged by 127.88% to $3.3 million in 2016, then tumbled by 97.04% to $99000.0 in 2017, then soared by 12266.67% to $12.2 million in 2018.
Business Quant data shows Shares Issued for ARMP at $12.2 million in Q4 2018, -$193000.0 in Q2 2018, and $198000.0 in Q1 2018.